Abstract. The aim of the present study was to determine the relative quantitative expression of hypoxia-inducible factor (HIF)-1α, -2α and -3α, and VEGF-A in laryngeal carcinoma. A total of 63 patients with carcinoma of the larynx were enrolled in the study. Total RNA was isolated from fresh, frozen normal and tumor tissues of each patient, and quantitative polymerase chain reaction was performed. HIF-1α was upregulated in the majority of patients (44 patients; 69.84%). By contrast, only 7 (11.11%) patients from the whole group displayed HIF-2α overexpression, while the HIF-3α isoform was silenced in the majority of patients (48 patients, 76.19%). A small group of 5 (7.94%) patients exhibited significant overexpression of the HIF-3α isoform. VEGF-A expression was significantly higher (P<0.05) in patients with upregulated HIF-1α (2.72±1.41 RQ) compared with patients without upregulated HIF-1α (1.86±1.46 RQ). There was a moderate positive correlation between mRNA expression levels of HIF-1α and VEGF-A (r s = 0.392; P<0.005). To the best of our knowledge, this study is first to report quantitative data with regard to the expression of all three HIF isoforms in malignant neoplasms. The findings suggest the existence of specific phenotypes of HIF expression in laryngeal carcinoma, where the HIF switch is absent.
Introduction
It is a well-established fact that rapid cell division in solid tumors leads to depletion of the oxygen levels and variable levels of hypoxia across the tumor. The latter is a major driving force for the process of endothelial proliferation and tumor angiogenesis. Squamous cell carcinoma of the larynx is the most common neoplasm of the head and neck. It is well-known that the rapid proliferation of malignant cells and the irregular local vasculature jointly favor the formation of hypoxic areas within human solid tumors including laryngeal cancer. Despite the vast amount of papers, there is a lack of quantitative studies reporting the levels of expression of hypoxia-inducible factors in this neoplasm. Hypoxia-inducible factors (HIFs) are essential in the primary transcriptional responses to hypoxic stress in normal and neoplastic cells. These molecules are heterodimeric transcription factors that activate a large number of target genes, including phosphoglycerate kinase and vascular endothelial growth factor (VEGF) A. This leads to increased glycolysis, endothelial proliferation and angiogenesis, which facilitates the adaptation of the tumor to hypoxia. HIFs are composed of α and β subunits; three α isoforms exist, which are normally rapidly degraded in an oxygen-dependent manner (1) (2) (3) (4) (5) , while the β subunit is expressed at constant level under normoxic conditions. HIF-1α and HIF-2α (also known as EPAS1) are structurally similar, and activate the transcription of target genes by binding to hypoxia response elements (HREs) or similar sequence elements. The presence of HREs has been demonstrated in a number of angiogenic genes, including VEGFA (6,7), VEGF receptor 1/fms-related tyrosine kinase 1 (8-10), erythropoietin (2, (11) (12) (13) (14) and endothelial nitric oxide synthase (15) (16) (17) (18) . Little is known about the third HIFα isoform. It has been demonstrated that a number of splice variants of HIF-3α may act as dominant-negative regulators of the other two α isoforms; however, its primary function, and the regulatory mechanism through which HIF-3α and its variants exert their effects, remains unclear based on currently available evidence (19) .
VEGF-A is a key regulator of angiogenesis, but has also been identified to be a multi-functional factor involved in tumor progression, immunosuppression and immune tolerance (20) . Endothelial cells are the primary targets of VEGF-A, which acts as a survival factor for these cells, and prevents endothelial apoptosis induced by serum starvation (21) (22) (23) (24) (25) 
Genetic testing
Total RNA extraction and cDNA synthesis. Total RNA was isolated from normal and tumor fresh frozen tissue samples of each patient using an RNeasy Mini kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol. The quality of RNA was assessed by denaturing electrophoresis on a formaldehyde gel. The amount of RNA was determined spectrophotometrically using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA). From each sample, 1 µg RNA underwent reverse transcription using a High-Capacity cDNA Reverse Transcription (RT) kit (Applied Biosystems Life Technologies, Foster City, CA, USA) according to manufacturer's recommendations. In brief, 2X RT master mix, prepared according to the manufacturer's instructions, was added to RNA in a total volume of 20 µl. Reverse transcription was performed in three steps: 25˚С for 10 min, 37˚С for 120 min and 85˚С for 5 min.
Quantitative polymerase chain reaction (PCR). In the present study, the expression of four genes, HIF-1α, HIF-2α, HIF-3α and VEGF-A, was analyzed. Quantitative PCR was performed in a 25-µl total volume of 1X RotorGene SYBR Green PCR Mix (Qiagen), 1X QuantiTect Primer Assay (Qiagen) for the respective gene (Hs_HIF1A_1_SG, Hs_ EPAS1_1_SG, Hs_HIF3A_1_SG, Hs_VEGFA_1_SG) and 100 ng cDNA. The conditions were as follows: Initial denaturation at 95˚С for 5 min, followed by 45 cycles of denaturation at 95˚С for 15 sec, primer annealing at 55˚С for 30 sec, and synthesis with data acquisition at 72˚С for 30 sec. Each sample was examined in triplicate, and the mean threshold cycle (Ct) values from the three repeats were used for the data analysis. Negative and no template controls were also evaluated. β-actin (Hs_ACTB_1_SG; QuantiTect Primer Assay) was used as a reference gene for normalization. To determine the relative expression of each gene in the tumor, the 2-ΔΔCt method was applied (26 ΔΔCt , where ΔΔCt = ΔCt T -ΔCt N . An RQ of >2 was defined as overexpression, and an RQ of <0.5 was defined as underexpression of the gene, in agreement with previous studies (27, 28) .
Statistical analysis. IBM SPSS Statistics 21 (IBM SPSS,
Armonk, NY, USA) was used for all statistical analyses. A two-sided t-test was used to calculate the statistical significance of the results. The χ 2 test was used to evaluate differences in mRNA expression levels of HIF-1α and VEGF-A. Spearman analysis was used to determine correlations. P<0.05 was considered to indicate a statistically significant difference.
Results
The mean age of the study group was 60.5 years, with a standard deviation of 7.8 years (range, 41-84 years). The cohort comprised 2 female and 61 male patients, all of whom had histologically verified squamous cell carcinoma of the larynx. Distribution according to tumor-node-metastasis classification was as follows: Stage T1, 2 patients (3.17%); T2, 7 patients (11.11%); T3, 23 patients (36.51%); and T4, 31 patients (49.21%) (29). Histologically verified lymph node metastases were present in 14 patients (22.22%) at the time of surgery.
HIF-1α was upregulated (RQ>2) in the majority of patients (44 patients, 69.84%) and normally expressed (0.5<RQ<2) in the remaining 19 (30.16%) patients. By contrast, HIF-2α overexpression (RQ>2) was only identified in 7 patients (11.11%); of the remaining 56 (88.89%) patients, 24 patients exhibited almost silenced HIF-2α expression (RQ<0.5), and the other 32 patients exhibited expression similar to that of the matched normal laryngeal samples (0.5<RQ<2). The HIF-3α isoform was markedly downregulated (RQ<0.5) in the majority of patients (48 patients, 76.19%) . Normal levels of HIF-3α mRNA expression (0.5<RQ<2) were registered in 10 (15.87%) patients and a small group of 5 (7.94%) patients exhibited significant overexpression of the HIF-3α isoform (RQ>2). For VEGF-A, 61.90% (39 patients) showed overexpression (RQ>2), 6.35% (4 patients) displayed low expression (RQ<0.5) and 31.75% (20 patients) exhibited normal expression levels (0.5<RQ<2) (Fig. 1) .
Quantitative analysis of the study group revealed mean values of HIF-1α mRNA expression that were 2.71 times higher than the corresponding normal laryngeal epithelium, while the expression levels of HIF-2α, HIF-3α and VEGF-A were 0.92, 0.50 and 2.98 times that of the normal epithelium, respectively. One patient was excluded as an outlier after the mRNA expression level of VEGF-A was measured to be 955 times higher in the tumor tissue compared with the corresponding normal laryngeal tissue (testing was repeated five times).
A χ 2 test for association was conducted between patients with upregulated and without upregulated mRNA expression of HIF-1α and VEGF-A. There was a statistically significant association between the overexpression of HIF-1α and VEGF-A (χ 2 1 =7.246, P=0.008). Spearman's rank correlation coefficient was used to assess the correlation between mRNA expression levels of HIF-1α and VEGF-A. Preliminary analyses revealed the association to be monotonic, as assessed by visual inspection of a scatterplot. Pearson's correlation could not be used, as the variables were not normally distributed, as assessed by a Shapiro-Wilk test (P>0.05). Six outliers were recognized and removed from the analyzed group. There was a moderate positive correlation between mRNA expression levels of HIF-1α and VEGF-A (r s = 0.392, P<0.005).
An independent-samples t-test was conducted to determine whether expression levels of VEGF-A differed significantly between patients with and without upregulated HIF-1α. VEGF-A expression was significantly higher (P<0.05; Fig. 2 ) in patients with upregulated HIF-1α (2.72±1.41 RQ) compared with patients without upregulated HIF-1α (1.86±1.46 RQ). There was homogeneity of variances, as assessed by Levene's test for equality of variances (P= 0.813), while no significant differences in VEGF-A levels between patients with and without upregulated HIF-2α were identified. Finally, an analysis of VEGF-A levels between patients with and without upregulated HIF-3α revealed a statistically significant difference (7.61±2.14 vs. 2.66±2.13, respectively; Fig. 3) .
A one-way analysis of variance was conducted to determine whether the levels of VEGF-A mRNA expression differed between patients of different T stages. Participants were classified into four groups: T1 stage (n=2), T2 stage (n=7), T3 stage (n=22) and T4 stage (n=31). Six outliers were recognized and removed from the analyzed group. There was homogeneity of variances, as assessed by Levene's test of homogeneity of variances (P=0.120). Data is presented as the mean ± standard deviation. The VEGF-A expression rate was significantly different between the groups (F=4.79, P= 0.005). VEGF-A expression increased from T1 stage patients (0.77±0.03), to T2 stage patients (1.11±0.61), to T3 stage patients (2.37±1.46) to T4 stage patients (2.98±1.40) (Fig. 4) .
Discussion
To the best of our knowledge, the presents study is the first to investigate the mRNA expression levels of all three isoforms of the HIF family in carcinoma tissue samples. Following a review of the literature, only 13 studies on the topic of laryngeal carcinoma and HIF were identified (Table I) . These studies all examined the expression of HIF-1α only, and none investigated HIF-1α mRNA expression levels from in vivo samples (30) (31) (32) (33) (34) (35) (36) (37) (38) (39) (40) (41) (42) . The current study is the first to present full quantitative data regarding the mRNA expression levels of HIF-1α and HIF-2α in laryngeal carcinoma samples, and is the first to report on the mRNA expression levels of HIF-3α in an in vivo study of a malignant neoplasm. Analysis of the results revealed a distinctive expression pattern among the majority of the patients: Overexpression of HIF-1α (69.84%), normal or downregulated levels of HIF-2α, and normal or downregulated levels of HIF-3α (92.06%). HIF-2α was demonstrated to be stabilized at moderate oxygen levels (2-5% O 2 ), whereas HIF-1α is upregulated only at lower oxygen levels (0-2% O 2 ) (reviewed in 43). Additionally, Holmquist-Mengelbier et al (30) demonstrated that HIF-1α is most active during short periods (2-24 h) of intense hypoxia or anoxia (<0.1% O 2 ), whereas HIF-2α may be active for a longer period of mild hypoxia (<5% O 2 ). This phenomenon is described in the literature as the HIF switch: HIF-1α drives the initial response to hypoxia, and HIF-2 subsequently takes over the major role during chronic hypoxic exposure (44) (45) (46) . The HIF switch is particularly evident during the development of renal cell carcinoma, where there is a gradual shift from HIF-1α to HIF-2α expression with increasing tumor grade (46) (47) (48) . In contrast to these findings, the results of the present study display a lack of such a HIF switch in laryngeal carcinoma: Of the 7 patients with upregulated HIF-2α, 4 also exhibited an upregulation in HIF-1α levels. Thus only three patients demonstrated a distinct HIF switch, despite 85.7% of the cohort having advanced-stage disease (T3 or T4 stage).
The statistically significant association between overexpression of HIF-1α and VEGF-A is expected, as this is consistent with the canonical HIF pathway: Overexpression of HIF-1α triggers the expression of VEGF-A (49). This is also supported by the fact that VEGF-A levels in the current study were significantly higher in patients with upregulated HIF-1α expression compared with those without upregulated HIF-1α expression. Additionally, there was a statistically significant correlation between the levels of expression of the two molecules, i.e., there was a quantitative association between the level of mRNA expression of HIF-1α and VEGF-A.
Another notable result from the present study was with regard to the mRNA expression of HIF-3α. HIF-3α is the most poorly studied isoform of the three, and in the review of the literature, no other studies were found that investigated in vivo expression in any malignant neoplasm. In the present study, the majority of the patients display silenced expression of HIF-3α, with the exception of a small group of five patients who exhibited upregulated mRNA expression levels. Compared with the remaining patients, significantly higher levels of VEGF-A expression were detected in this group (mean RQ, 7.61±2.14 vs. 2.66±2.13; Fig. 3 ). Various possible effects of HIF-3α have been reported due to its multiple splice variants. Of major significance is the downregulatory function of HIF-3α on HIF-1α and HIF-2α activity (reviewed in 43). This indicates that the overexpression of VEGF-A may be a driving force for the upregulation of HIF-3α, as the latter would act a negative feedback regulator of the canonical HIF pathway. Despite this, there were also a few cases in the present cohort of patients in which a significant upregulation of VEGF-A plus silenced HIF-3α was detected; other regulatory factors must play a role in these cases.
Finally, the clinical correlation between VEGF-A expression and the stage of the tumor may be explained by the growing size of the lesion and the expansion of the process of neoangiogenesis, in which VEGF-A is essential (49) .
The present study reports, for the first time, full quantitative data on the expression of all three isoforms of the HIFs in malignant neoplasms. The findings indicate a specific phenotype of HIF expression in laryngeal carcinoma, where the HIF switch is absent. Further investigations are required to uncover the obscure nature of HIF-3α, and the factors that determine which isoform, HIF-1α or HIF-2α, would be the major driving force of the canonical HIF pathway in neoplasms.
